Having steered their series Making a Murderer to global phenomenon status following its addition to Netflix last year, the directors behind the documentary series have lined up a new project that seems like it'll be just as enthralling.

Filmmakers Laura Ricciardi and Moira Demos are teaming with George Clooney to produce their follow-up project that will adapt a Huffington Post article named "America's Most Admired Lawbreaker."

Originally written by Steven Brill, the serialised article - published in 2015 - focuses on a division of pharmaceutical company Johnson & Johnson that created and mass produced an antipsychotic drug to children and the elderly without detailing its negative side effects.

Download the new Independent Premium app

Sharing the full story, not just the headlines

While selling over a reported $30 billion worth of the drug globally, the company ended up agreeing to pay just over $2 billion in penalties.

Variety reports that Nicki Paluga will adapt the article into a TV series to be directed by Ricciardi and Demos. Clooney will produce alongside Grant Heslov (Argo) under their Smokehouse Pictures company that's teamed with Sonar Entertainment in a new deal.

It is unclear how many episodes the series will contain or when it is expected to air.

Following the level of recognition achieved by Making a Murderer subject Steven Avery - the story of whom took the duo ten years to make into a series - we're sure Johnson & Johnson are preparing for one hell of a media storm.

Comments

Share your thoughts and debate the big issues

Learn more
Please be respectful when making a comment and adhere to our Community Guidelines.
  • You may not agree with our views, or other users’, but please respond to them respectfully
  • Swearing, personal abuse, racism, sexism, homophobia and other discriminatory or inciteful language is not acceptable
  • Do not impersonate other users or reveal private information about third parties
  • We reserve the right to delete inappropriate posts and ban offending users without notification

You can find our Community Guidelines in full here.

Create a commenting name to join the debate

Please try again, the name must be unique Only letters and numbers accepted
Loading comments...
Loading comments...
Please be respectful when making a comment and adhere to our Community Guidelines.
  • You may not agree with our views, or other users’, but please respond to them respectfully
  • Swearing, personal abuse, racism, sexism, homophobia and other discriminatory or inciteful language is not acceptable
  • Do not impersonate other users or reveal private information about third parties
  • We reserve the right to delete inappropriate posts and ban offending users without notification

You can find our Community Guidelines in full here.

Loading comments...
Loading comments...